Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Adjunctive Quetiapine in the Treatment of Refractory Social Anxiety Disorder in Adults

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2010 by Cambridge Health Alliance.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
AstraZeneca
Information provided by:
Cambridge Health Alliance
ClinicalTrials.gov Identifier:
NCT01224067
First received: September 10, 2010
Last updated: October 18, 2010
Last verified: October 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: November 2010
  Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)